Kaeda🔍 Search 518 cases — "data $1M", "solo founder", "community"…
← All cases

ComplyAdvantage

Founded 2014 · London · AML/KYC screening
👤 Charles Delingpole (Founded The Student Room at 16, then MarketInvoice; lived AML pain from the fintech side before selling the fix.)🌐 sitedelingpole.com𝕏LinkedIn

A fintech founder hit AML pain at MarketInvoice, then built the risk database rivals now have to buy.

Will it work? · our read
Fines drive sales. AML rules make screening non-optional, so demand is durable. The catch: the biggest banks still run incumbent databases, and the founder has stepped back to chairman.
01How the money moves
Regulator mandates AML screening for every regulated firm
Fintechs and banks plug into ComplyAdvantage's real-time risk database
They pay recurring API and seat fees to stay compliant
02The numbers
£42M (about $53M)EstimateTurnover est. (GlobalDB)
FY end Mar 2024source: £42M
£42M
turnover · $53M
500
customers
$88.2M
total raised
Turnover is a third-party estimate (GlobalDatabase) of an unread Cos House filing; customers and funding are also third-party estimates.
Standalone turnover for IVXS UK Ltd (est., not group); Latka pegs recurring ARR near $27M.
🔒
You have the verdict. Members get the work behind it.
  • The CENTS scorecard — where it's strong, where it's soft
  • The founder's key move, and the counter-move
  • How it could die — the evidence, and how sure we are
  • The case against our own call
  • A 🚀 launchpad prompt — the case, as a plan for your business
We rate our own confidence — and argue against ourselves. Nobody else in this category does.
Sources always public on all 518 cases · cancel anytime · 14-day refund
See a full teardown, free → Transistor.fm
SourcesSources last checked 30 July 2026
GlobalDatabase — IVXS UK Ltd (ComplyAdvantage) FY24 standalone turnover £42M, estimated from Companies House data (accounts unconsolidated, per GlobalDatabase's own tag)Companies House — IVXS UK Limited, accounts to 31 Mar 2025 (filing is a scanned PDF, unread)Latka — est. $27.3M ARR, 500 customers, $88.2M raisedComplyAdvantage — products: sanctions, PEP, adverse media, transaction monitoringBalderton — Charles Delingpole founder profile (The Student Room, MarketInvoice)
Revenue is EST, not FILED: £42M turnover for IVXS UK Limited (ComplyAdvantage's UK entity) for the year ended 31 Mar 2024, taken from GlobalDatabase, a third-party aggregator that extracts and estimates figures from Companies House data. GlobalDatabase tags this filing 'Consolidated A/cs: N' — it is IVXS UK Limited's own standalone turnover, not a consolidated group figure, so this is one entity's number, not the wider ComplyAdvantage group. The primary Companies House filing itself is a scanned PDF with no text layer; nobody, aggregator included, has read the exact figure from the source document itself. A newer FYE Mar 2025 filing exists but its figures were also not machine-readable. Turnover (about $53M) exceeds Latka's $27.3M ARR estimate, which counts recurring revenue only. Customer count (500) and funding ($88.2M) are third-party (Latka/Crunchbase), not first-party. Founder Charles Delingpole is now Executive Chairman; Vatsa Narasimha is CEO. verified:false because the headline figure is a third-party estimate of an unreadable filing, not a number anyone has directly read. We never score you.